Fortress Biotech, Inc. (FBIO) stock
FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
$1.88−0.11 (-5.53%)
Close on Nov 13, 2026Market cap $69.14MP/E –Yield –
Fortress Biotech cash
Cash and short-term investments held at the end of each period.
Fortress Biotech's cash was $152.19M at Sep 30, 2026. For fiscal 2025 it was $79.38M, up 35.0% from the year before. Over ten years it grew -2.1% a year on average. The highest annual figure on record is $307.96M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $79.38M | +35.0% |
| FY2024 | Dec 31, 2024 | $58.82M | -29.4% |
| FY2023 | Dec 31, 2023 | $83.37M | -53.9% |
| FY2022 | Dec 31, 2022 | $180.95M | -41.2% |
| FY2021 | Dec 31, 2021 | $307.96M | +31.1% |
| FY2020 | Dec 31, 2020 | $235.00M | +53.2% |
| FY2019 | Dec 31, 2019 | $153.43M | +54.7% |
| FY2018 | Dec 31, 2018 | $99.19M | -32.5% |
| FY2017 | Dec 31, 2017 | $146.96M | +79.0% |
| FY2016 | Dec 31, 2016 | $82.11M | -16.4% |
| FY2015 | Dec 31, 2015 | $98.18M | +40.7% |
| FY2014 | Dec 31, 2014 | $69.76M | -29.9% |
| FY2013 | Dec 31, 2013 | $99.52M | +147.6% |
| FY2012 | Dec 31, 2012 | $40.20M | +73.6% |
| FY2011 | Dec 31, 2011 | $23.16M | +55.8% |
| FY2010 | Dec 31, 2010 | $14.86M | +884.2% |
| FY2009 | Dec 31, 2009 | $1.51M | +21471.4% |
| FY2008 | Dec 31, 2008 | $7.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $152.19M | +76.5% |
| Q2 FY2026 | Jun 30, 2026 | $196.58M | +164.3% |
| Q1 FY2026 | Mar 31, 2026 | $255.84M | +180.1% |
| Q4 FY2025 | Dec 31, 2025 | $79.38M | +35.0% |
| Q3 FY2025 | Sep 30, 2025 | $86.22M | +46.5% |
| Q2 FY2025 | Jun 30, 2025 | $74.39M | -2.4% |
| Q1 FY2025 | Mar 31, 2025 | $91.34M | +9.0% |
| Q4 FY2024 | Dec 31, 2024 | $58.82M | -29.4% |
| Q3 FY2024 | Sep 30, 2024 | $58.85M | -18.6% |
| Q2 FY2024 | Jun 30, 2024 | $76.20M | -2.3% |
| Q1 FY2024 | Mar 31, 2024 | $83.77M | -45.1% |
| Q4 FY2023 | Dec 31, 2023 | $83.37M | -53.9% |
| Q3 FY2023 | Sep 30, 2023 | $72.31M | -65.3% |
| Q2 FY2023 | Jun 30, 2023 | $78.02M | -68.6% |
| Q1 FY2023 | Mar 31, 2023 | $152.48M | -47.0% |
| Q4 FY2022 | Dec 31, 2022 | $180.95M | -41.2% |
| Q3 FY2022 | Sep 30, 2022 | $208.35M | -17.6% |
| Q2 FY2022 | Jun 30, 2022 | $248.77M | -9.5% |
| Q1 FY2022 | Mar 31, 2022 | $287.51M | -0.8% |
| Q4 FY2021 | Dec 31, 2021 | $307.96M | +31.1% |
| Q3 FY2021 | Sep 30, 2021 | $252.72M | +15.7% |
| Q2 FY2021 | Jun 30, 2021 | $274.99M | +50.0% |
| Q1 FY2021 | Mar 31, 2021 | $289.90M | +90.1% |
| Q4 FY2020 | Dec 31, 2020 | $235.00M | +53.2% |
| Q3 FY2020 | Sep 30, 2020 | $218.39M | +40.0% |
| Q2 FY2020 | Jun 30, 2020 | $183.28M | +7.5% |
| Q1 FY2020 | Mar 31, 2020 | $152.52M | +10.9% |
| Q4 FY2019 | Dec 31, 2019 | $153.43M | +54.7% |
| Q3 FY2019 | Sep 30, 2019 | $156.02M | +36.3% |
| Q2 FY2019 | Jun 30, 2019 | $170.48M | +28.8% |
| Q1 FY2019 | Mar 31, 2019 | $137.56M | -12.9% |
| Q4 FY2018 | Dec 31, 2018 | $99.19M | -32.5% |
| Q3 FY2018 | Sep 30, 2018 | $114.45M | -33.7% |
| Q2 FY2018 | Jun 30, 2018 | $132.39M | -27.0% |
| Q1 FY2018 | Mar 31, 2018 | $157.93M | +4.6% |
| Q4 FY2017 | Dec 31, 2017 | $146.96M | +79.0% |
| Q3 FY2017 | Sep 30, 2017 | $172.55M | – |
| Q2 FY2017 | Jun 30, 2017 | $181.28M | – |
| Q1 FY2017 | Mar 31, 2017 | $150.93M | – |
| Q4 FY2016 | Dec 31, 2016 | $82.11M | – |
See a number that looks wrong?